Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

American Journal of Human Genetics

Volumn 62, Issue 1, 1998, Pages 145-158

  Parmigiani, Giovanni ^a   Berry, Donald A ^a   Aguilar, Omar ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BAYES THEOREM; BREAST CANCER; CANCER SUSCEPTIBILITY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC COUNSELING; HETEROZYGOTE; HUMAN; OVARY CANCER; PRIORITY JOURNAL; PROBABILITY;

EID: 0031917403     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301670     Document Type: Article

References (29)

1. Andersen TI (1996) Genetic heterogeneity in breast cancer susceptibility. Acta Oncol 35(4): 407-410
2. Berry DA, Parmigiani G, Sanchez J, Schildkraut JM, Winer E (1997) Assessing the probability of carrying a breast cancer gene BRCA1 based on family history. J Natl Cancer Inst 89(3): 9-20
3. Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48:232-242
4. Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer: implications for risk prediction. Cancer 73:643-651
5. Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, et al (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409-1415
6. Easton DF, Ford D, Bishop DT, Breast Cancer Linkage Consortium (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265-271
7. Easton DF, Steele L, Fields P, Ormiston W, Averill D, Daly PA, McManus R, et al (1997) Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 61:120-128
8. Falconer DS, Mckay TFC (1996) Quantitative genetics. Longman, Harlow, United Kingdom
9. Ford D, Easton DF (1995) The genetics of breast and ovarian cancer. Br J Cancer 72:805-812
10. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, et al (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 226: 120-122
11. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886
12. Håkansson S, Johannsson O, Johansson U, Sellberg G, Loman N, Gerdes A-M, Holmberg E, et al (1997) Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet 60: 1068-1078
13. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, Weber BL (1995) Assessment and counseling for women with a family history of breast cancer: a guide for clinicians. JAMA 273:577-585
14. Houwing-Duistermaat JJ, Van Houwelingen JC (1997) A family history score for breast cancer. Genet Epidemiol 14:530
15. Leal SM, Ott J (1994) A likelihood approach to calculating risk support interval. Am J Hum Genet 54:913-917
16. Miki Y, Swensen J, Shattuck-Eidens DJ, Futreal PA, Harshman K, Tavtigian S, Liu Q (1994) A strong candidate for the breast and ovarian cancer susceptibility: gene BRCA1. Science 266(7): 66-71
17. Moolgavkar SH, Stevens RG, Lee JAH (1979) Effect of age on incidence of breast cancer in females. J Natl Cancer Inst 62:493-501
18. Murphy EA, Mutalik GS (1969) The application of Bayesian methods in genetic counseling. Hum Hered 19:126-151
19. Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, et al (1996) The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 14:188-190
20. Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185-187
21. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, et al (1995) A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. JAMA 273:535-541
22. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401-1408
23. Szabo CI, King M-C (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013-1020
24. Szolovits P, Pauker S (1992) Pedigree analysis for genetic counseling, In: Lun KC, Degoulet P, Piemme TE, Rienhoff O (eds) MEDINFO-92: proceedings of the Seventh Conference on Medical Informatics. Elsevier, New York, pp 679-683
25. Thompson EA (1986) Pedigree analysis in human genetics. Johns Hopkins University Press, Baltimore
26. Thompson EA, Guo SW (1991) Evaluation of likelihood ratios for complex genetic models. IMA J Math Appl Med Biol 8: 149-169
27. Vehmanen P, Friedman LS, Eerola H, Sarantaus L, Pyrhönen S, Ponder BAJ, Muhonen T, et al (1997) A low proportion of BRCA2 mutations in Finnish breast cancer families. Am J Hum Genet 60:1050-1058
28. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792
29. Yancik R (1993) Ovarian cancer: age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer 71 Suppl 2:517-523